Andre Bessette

Andre Bessette is the Chief Executive Officer and co-founder of Eclipse Regenesis, a company focused on developing innovative treatments for Short Bowel Syndrome (SBS) and intestinal failure. Under his leadership, Eclipse Regenesis has made significant strides in clinical research, including successfully enrolling and treating its first adult SBS patient with their Eclipse XL1 System, a device designed to stimulate the growth of new intestinal tissue.12

Bessette has extensive experience in the medical device industry, having spent over 28 years in various management roles. Prior to his position at Eclipse Regenesis, he was a partner at Asclepius Medical Ventures and served as the Chief Commercial Officer at Enso Relief, which was later acquired by Hinge Health.3 His background combines expertise in medical technology and business strategy, which has been instrumental in advancing the company's mission to improve clinical outcomes for patients with SBS.23